Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.24.2.u1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows used in operating activities:          
Net loss $ (7,252) $ (14,129) $ (16,892) $ (27,805)  
Items not involving cash:          
Stock-based compensation 207 769 1,016 2,643  
Depreciation and amortization 8 22 24 50  
Loss on disposal of property and equipment 66 0 76 0  
Amortization of right-of-use assets 94 92 187 195  
Interest on lease liabilities 18 25 37 50  
Unrealized (gain)/loss on short-term investment 1 2 0 (2)  
Accrued interest on investments (9) (17) 0 (12)  
Deferred financing expenses 0 50 0 50  
Changes in non-cash operating assets and liabilities:          
Prepaid expenses 560 311 806 567  
Other current assets 81 (55) 7 40  
Operating lease liabilities (119) (45) (234) (173)  
Accounts payable to related parties 0 (1,389) (2,554) (93)  
Accounts payable 4,690 (629) 3,619 (2,732)  
Accrued liabilities (4,123) 1,490 (3,633) 2,427  
Cash used in operating activities (5,778) (13,503) (17,541) (24,795)  
Cash flows from financing activities:          
Issuances of common shares and warrants under the Registered Direct Offering 4,140 0 4,140 0  
Issuance of common shares and warrants under the S-1 Filing 0 0 8,127 0  
Shares issuances to Hanmi under subscription agreement 0 0 3,702 0  
Cost of offering (177) (5) (177) (5)  
Issuance of common shares under the ESPP plan 0 0 18 16  
Cash from financing activities 4,754 1,104 16,601 1,154  
Cash flows from/(used in) investing activities:          
Disposal/(purchase) of property and equipment, net 17 (29) 18 (29)  
Maturity (acquisition) of investments, net 1,992 (1,931) 0 (4,902)  
Cash from/(used in) investing activities 2,009 (1,960) 18 (4,931)  
Effect of exchange rate fluctuations on cash and cash equivalents (1) (3) 0 2  
Increase/(decrease) in cash and cash equivalents 984 (14,362) (922) (28,570)  
Cash and cash equivalents, beginning of period 7,346 22,762 9,252 36,970 $ 36,970
Cash and cash equivalents, end of period 8,330 8,400 8,330 8,400 $ 9,252
The 2023 CMPO [Member]          
Cash flows from financing activities:          
Issuance of common shares 694 0 694 0  
The 2022 ATM Offering [Member]          
Cash flows from financing activities:          
Issuance of common shares $ 97 $ 1,109 $ 97 $ 1,143